Skip to main content
    I

    Ironwood Pharmaceuticals Inc (IRWD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $3.77
    +0.17 (+4.72%)

    Market Cap: $594.86M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(20/39)
    Avg Surprise
    -49.28%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.31
    Range$0.30 - $0.32
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.29+6.9%
    60d ago$0.29+6.9%
    30d ago$0.310.0%
    7d ago$0.310.0%
    Current$0.31
    Revenue Consensus
    $122M
    Range$120M - $122M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.39
    Range$0.38 - $0.40
    2 analysts
    Revenue Consensus
    $143M
    Range$138M - $147M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.39---
    Sep 26EST
    		-$0.31---
    Jun 26
    Reported Aug 6
    		$0.31$0.26+19.23%Beat+121.4%
    Mar 26
    Reported May 7
    		$0.24$0.24+0.00%Beat+271.4%
    Dec 25
    Reported Feb 25
    		$-0.01$0.02-159.52%Miss-150.0%
    Sep 25
    Reported Nov 10
    		$0.24$0.12+100.00%Beat+1100.0%
    Jun 25
    Reported Aug 7
    		$0.14$-0.02+800.00%Beat+2692.6%
    Mar 25
    Reported May 7
    		$-0.14$-0.03-366.67%Miss-600.0%
    Dec 24
    Reported Feb 27
    		$0.02N/A-74.19%Miss+300.0%
    Sep 24
    Reported Nov 7
    		$0.02N/A-80.00%Miss-83.3%
    Jun 24
    Reported Aug 8
    		$-0.01N/A-103.86%Miss+99.9%
    Mar 24
    Reported May 9
    		$-0.02N/A-113.33%Miss-108.0%
    Dec 23
    Reported Feb 15
    		$-0.01N/A-105.00%Miss-103.7%
    Sep 23
    Reported Nov 9
    		$0.12$0.16-25.00%Miss-57.1%
    Jun 23
    Reported Aug 8
    		$-6.71$0.25-2784.00%Miss-3295.2%
    Mar 23
    Reported May 4
    		$0.25$0.24+4.17%Beat+19.0%
    Dec 22
    Reported Feb 16
    		$0.27$0.26+3.85%Beat+0.0%
    Sep 22
    Reported Nov 3
    		$0.28$0.27+3.70%Beat-15.2%
    Jun 22
    Reported Aug 4
    		$0.21$0.30-30.00%Miss-38.2%
    Mar 22
    Reported May 5
    		$0.21$0.26-19.23%Miss-12.5%
    Dec 21
    Reported Feb 17
    		$0.27$0.34-20.59%Miss-25.0%
    Sep 21
    Reported Nov 4
    		$0.33$0.32+3.13%Beat+43.5%
    Jun 21
    Reported Aug 5
    		$0.34$0.22+54.55%Beat+112.5%
    Mar 21
    Reported May 6
    		$0.24$0.22+9.09%Beat+500.0%
    Dec 20
    Reported Feb 17
    		$0.36$0.29+24.14%Beat+20.0%
    Sep 20
    Reported Nov 5
    		$0.23$0.15+53.33%Beat-42.5%
    Jun 20
    Reported Aug 6
    		$0.16$0.10+60.00%Beat+60.0%
    Mar 20
    Reported May 6
    		$0.04$0.05-20.00%Miss+115.4%
    Dec 19
    Reported Feb 13
    		$0.30$0.24+25.00%Beat+1600.0%
    Sep 19
    Reported Oct 31
    		$0.40$0.12+233.33%Beat+205.3%
    Jun 19
    Reported Jul 30
    		$0.10$-0.02+600.00%Beat+135.7%
    Mar 19
    Reported May 2
    		$-0.26$-0.23-13.04%Miss+3.7%
    Dec 18
    Reported Feb 13
    		$-0.02N/A+89.47%Beat+85.7%
    Sep 18
    Reported Nov 6
    		$-0.38$-0.20-90.00%Miss-111.1%
    Jun 18
    Reported Aug 6
    		$-0.28$-0.23-21.74%Miss+0.0%
    Mar 18
    Reported May 1
    		$-0.27$-0.23-17.39%Miss+18.2%
    Dec 17
    Reported Feb 15
    		$-0.14$-0.20+30.00%Beat-55.6%
    Sep 17
    Reported Nov 2
    		$-0.18$-0.24+25.00%Beat-
    Jun 17
    Reported Aug 3
    		$-0.28$-0.23-21.74%Miss-
    Mar 17
    Reported May 8
    		$-0.33$-0.21-57.14%Miss-
    Dec 16
    Reported Feb 21
    		$-0.09N/A+62.50%Beat-

    Key Metrics

    Valuation
    P/E Ratio4.83EV/EBITDA3.96x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin33.40%Operating Margin70.20%
    ROE-575.00%ROIC65.74%
    Financial Health
    Debt/Equity-2.43xInterest Coverage7.18x
    Current Ratio6.06xQuick Ratio6.06x
    Trading Statistics
    Beta0.22Avg Volume2.27M
    52-Week High$5.7852-Week Low$1.43

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.71
    SMA 20$3.95
    SMA 50$4.11
    SMA 200$4.02
    EMA 10$3.76
    EMA 20$3.87
    EMA 50$4.00
    EMA 200$3.70

    MACD

    Line: -0.13Signal: -0.12Hist: -0.02

    ADX

    ADX: 18.6+DI: 24.0-DI: 28.7

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down96.0
    PSAR$3.51

    Bollinger Bands

    Upper Band$4.54
    Lower Band$3.35
    %B Position3016%(Upper)
    Band Width0.35

    RSI (14-Day)

    Neutral
    44.1

    Momentum Oscillators

    Stoch %K19.5
    Stoch %D17.3
    Williams %R-60.6
    ROC (10d)0.3%
    Momentum0.01
    CCI (20d)-51.3
    MFI (14d)42.3

    Volatility Measures

    ATR (14d)$0.20(5.2%)
    StdDev (20d)0.30
    Hist Vol48.6%(High)

    Volume Flow

    VWAP$3.76
    OBV124.0M
    AD Line-101.2M
    CMF (20d)0.034

    Volume Metrics

    Avg Vol (20d)2.3M
    Vol Ratio0.9x
    VWMA (20d)$4.01

    Pivot Points

    R3$3.77
    R2$3.70
    R1$3.65
    Pivot Point$3.58
    S1$3.53
    S2$3.46
    S3$3.41

    Advanced Oscillators

    TSI-18.64
    Ultimate Osc47.2
    KST-109.96

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$113.04M$106.51M$47.71M$122.06M$85.24M$41.14M$90.55M$91.59M$94.40M$74.88M$117.55M$113.74M
    Cost of Revenue$0$0$460,000$0$0$0$78.48M$0$0$0$512,000$0
    Gross Profit$113.04M$106.51M$47.71M$122.06M$85.24M$41.14M$90.55M$91.59M$94.40M$74.88M$117.55M$113.74M
    Operating Expenses$33.73M$33.93M$40.90M$46.58M$39.92M$70.25M$59.05M$65.96M$69.42M$63.86M$79.96M$73.72M
    R&D$22.42M$21.94M$21.86M$22.47M$23.37M$27.43M$25.39M$29.83M$30.39M$25.82M$40.68M$32.98M
    SG&A$11.31M$12.03M$19.29M$21.91M$16.80M$24.26M$33.59M$36.11M$36.96M$37.60M$38.67M$36.05M
    Operating Income$79.31M$72.57M$6.80M$75.48M$45.32M$-29,108,000$31.49M$25.64M$24.98M$11.02M$37.59M$40.02M
    Interest Income$1.58M$1.70M$1.46M$930,000$818,000$869,000$778,000$1.15M$1.37M$1.17M$1.19M$1.75M
    Interest Expense$7.20M$9.14M$7.89M$8.43M$8.36M$8.07M$8.91M$9.42M$7.47M$7.23M$8.42M$9.84M
    Income Before Tax$73.73M$65.17M$455,000$68.02M$37.82M$-36,272,000$24.00M$17.37M$18.88M$4.96M$30.36M$31.93M
    Income Tax Expense$22.44M$24.40M$2.73M$27.94M$14.22M$1.11M$21.74M$13.72M$19.74M$9.12M$32.10M$17.98M
    Net Income$51.29M$40.77M$-2,276,000$40.08M$23.60M$-37,386,000$2.26M$3.65M$-860,000$-4,162,000$-1,745,000$13.95M
    EBITDA$79.81M$73.06M$7.34M$76.00M$45.83M$-28,592,000$32.62M$26.14M$25.48M$11.53M$38.69M$41.12M
    EBIT$79.35M$72.61M$6.88M$75.52M$45.36M$-29,071,000$32.13M$25.64M$24.98M$11.02M$37.59M$40.02M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IRWD

    News

    Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com

    This article announces the filing of Form 144 for IRONWOOD PHARMACEUTICALS INC on September 27. Form 144 is a notice of the intent to sell restricted securities. The brief notice was published by Investing.com.

    Investing.com UK•9/27/26•Neutral

    Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com

    This article announces the filing of Form 144 for IRONWOOD PHARMACEUTICALS INC on September 27. Form 144 is a notice of the intent to sell restricted securities...

    Investing.com Nigeria•9/27/26•Neutral

    Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com

    The article is a Form 144 filing for IRONWOOD PHARMACEUTICALS INC, dated September 27. It simply states the company name and the date of the filing...

    Investing.com India•9/27/26•Neutral

    Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com

    This article announces a Form 144 filing for IRONWOOD PHARMACEUTICALS INC (IRWD) on September 27. A Form 144 is a notice of the intent to sell restricted securities...

    Investing.com Australia•9/26/26•Neutral

    83,306 shares to cover taxes: Ironwood Pharmaceuticals (IRWD) ex-officer proposes a sale

    A former officer of Ironwood Pharmaceuticals (IRWD), Michael Shetzline, has proposed selling 83,306 Class A common shares valued at approximately $377,376.18. This sale is intended to cover taxes associated...

    Stock Titan•9/23/26•Neutral

    IRWD Valuation and Fair Value

    P/E
    4.8x
    Forward P/E
    12.3x
    EV/EBITDA
    4.0x
    PEG
    -0.3x
    P/B
    -3.8x
    See GNG's fair value

    IRWD Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    70.2%
    Net margin
    33.4%
    ROIC
    65.7%
    ROE
    -575.0%
    FCF margin
    47.7%

    IRWD Competitors

    CompanyTicker
    Olema Pharmaceuticals IncOLMA
    Weave Communications IncWEAV
    Phathom Pharmaceuticals IncPHAT
    Nuvectis Pharma IncNVCT
    Sophia Genetics SASOPH
    Climb Bio IncCLYM
    ProKidney Corp.PROK
    Solid Biosciences LLCSLDB

    Sector: Healthcare

    IRWD Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    1
    Buy
    1
    Hold
    2
    Sell
    0
    Strong Sell
    0

    IRWD Bull Case vs Bear Case

    Bull case

    • IRWD earns a 65.7% return on invested capital.
    • IRWD converts 47.7% of revenue into free cash flow.
    • IRWD has a 33.4% net profit margin.

    Bear case

    • IRWD beat EPS estimates in 37.5% of its last 8 reported quarters.

    IRWD Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    29.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.31
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About IRWD

    Does IRWD pay dividends?

    Ironwood Pharmaceuticals Inc (IRWD) does not currently pay a regular dividend.

    What is IRWD's P/E ratio?

    Ironwood Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 4.83.

    What is IRWD's market cap?

    Ironwood Pharmaceuticals Inc (IRWD) has a market capitalization of $594.86M with a current stock price of $3.77.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In